[Federal Register Volume 83, Number 70 (Wednesday, April 11, 2018)]
[Notices]
[Pages 15576-15577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07416]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-0981]


Preparation for International Cooperation on Cosmetics Regulation 
Twelfth Annual Meeting; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing the 
following public meeting entitled ``International Cooperation on 
Cosmetics Regulation (ICCR)--Preparation for ICCR-12 Meeting.'' The 
purpose of the public meeting is to invite public input on various 
topics pertaining to the regulation of cosmetics. We may use this input 
to help us prepare for the ICCR-12 meeting that will be held July 10 to 
12, 2018, in Tokyo, Japan.

DATES: The public meeting will be held on June 7, 2018, from 2 p.m. to 
4 p.m. See the SUPPLEMENTARY INFORMATION section for registration date 
and information.

ADDRESSES: The public meeting will be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Jonathan Hicks, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-125), 
College Park, MD 20740, [email protected], 240-402-1375.

SUPPLEMENTARY INFORMATION:

I. Background

    The intention of the ICCR multilateral framework is to pave the way 
for the removal of regulatory obstacles to international trade while 
maintaining global consumer protection. The purpose of the meeting is 
to invite public input on various topics pertaining to the regulation 
of cosmetics. We may use this input to help us prepare for the ICCR-12 
meeting that will be held July 10 to 12, 2018, in Tokyo, Japan.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from Brazil, Canada, the European Union, Japan, and the 
United States of America. These regulatory authority members will 
engage in constructive dialogue with their relevant cosmetics industry 
trade

[[Page 15577]]

associations and public advocacy groups. Currently, the ICCR members 
are: The Brazilian Health Surveillance Agency; Health Canada; the 
European Commission Directorate-General for Internal Market, Industry, 
Entrepreneurship, and Small and Medium-sized Enterprises; the Ministry 
of Health, Labor, and Welfare of Japan; and FDA. All decisions are made 
by consensus and will be compatible with the laws, policies, rules, 
regulations, and directives of the respective administrations and 
governments. Members will implement and/or promote actions or documents 
within their own jurisdictions and seek convergence of regulatory 
policies and practices. Successful implementation will need input from 
stakeholders.

II. Topics for Discussion at the Public Meeting

    We will make the agenda for the public meeting available on the 
internet at https://www.fda.gov/Cosmetics/InternationalActivities/ICCR/default.htm. Depending on the number of requests for oral 
presentations, we intend to have an agenda available by May 31, 2018.

III. Participating in the Public Meeting

    Registration: To register for the public meeting, send registration 
information (including your name, title, affiliation, address, email, 
and telephone), to Jonathan Hicks by May 24, 2018 (see FOR FURTHER 
INFORMATION CONTACT). If you would like to listen to the meeting by 
phone, please submit a request for a dial-in number by May 24, 2018. If 
you need special accommodations due to a disability, please contact 
Jonathan Hicks by May 31, 2018.
    Requests for Oral Presentations: If you wish to make an oral 
presentation, you should notify Jonathan Hicks by May 24, 2018, and 
submit a brief statement of the general nature of the evidence or 
arguments that you wish to present, your name, title, affiliation, 
address, email, and telephone, and indicate the approximate amount of 
time you need to make your presentation. You may present proposals for 
future ICCR agenda items, data, information, or views, in person or in 
writing, on issues pending at the public meeting. There will be no 
presentations by phone. Time allotted for oral presentations may be 
limited to 10 minutes or less for each presenter, depending on the 
number of requests received.
    Transcripts: Please be advised that as soon as a transcript of the 
public meeting is available, it will be accessible at https://www.regulations.gov. It may also be viewed at the Dockets Management 
Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 
1061, Rockville, MD 20850.

    Dated: April 5, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-07416 Filed 4-10-18; 8:45 am]
 BILLING CODE 4164-01-P


